Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jiang, Hequn ^a   Dai, Jingyao ^b   Huang, Xiaojun ^c   Chen, Yibing ^c   Qu, Ping ^c   Li, Jibin ^c   Yi, Cheng ^a   Yang, Yefa ^d   Zhang, Kejing ^e   Huang, Qichao ^a,c  

^a SICHUAN UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e NORTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACACA PROTEIN, HUMAN; ACETYL COENZYME A CARBOXYLASE; FASN PROTEIN, HUMAN; FATTY ACID SYNTHASE;

ADOLESCENT; ADULT; AGED; ALLELE; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW UP; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; LIPOGENESIS; LIVER NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; YOUNG ADULT;

ACETYL-COA CARBOXYLASE; ADOLESCENT; ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; FATTY ACID SYNTHASE, TYPE I; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; LIPOGENESIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84926429785     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09536     Document Type: Article

References (35)

1. Thomas, M. B., Zhu, A. X. Hepatocellular carcinoma: the need for progress. J Clin Oncol. 23, 2892-9 (2005).
2. Mann, C. D. et al. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer. 43, 979-992 (2007).
3. Swinnen, J. V., Brusselmans, K., Verhoeven, G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care. 9, 358-65 (2006).
4. Swinnen, J. V. et al. Androgens, lipogenesis and prostate cancer. J Steroid Biochem Mol Biol. 92, 273-9 (2004).
5. Shurbaji, M. S., Kalbfleisch, J. H., Thurmond, T. S. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol. 27, 917-21 (1996).
6. Simons, K., Toomre, D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 1, 31-9 (2000).
7. Li, N. et al. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Nutr Cancer. 64, 864-70 (2012).
8. Migita, T. et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst. 101, 519-32 (2009).
9. Lin, R. et al. Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth. Mol Cell. 51, 506-18 (2013).
10. Chajes, V., Cambot, M., Moreau, K., Lenoir, G. M., Joulin, V. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 66, 5287-94 (2006).
11. Kuhajda, F. P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 16, 202-8 (2000).
12. Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140, 1071-1083. e5 (2011).
13. Alo, P. L. et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 77, 474-82 (1996).
14. Kao, Y. C. et al. Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma. Tumour Biol 34, 759-68 (2013).
15. Ogino, S. et al. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 26, 5713-20 (2008).
16. Rahman, M. T. et al. Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas. Br J Cancer. 107, 300-7 (2012).
17. Cerne, D., Zitnik, I. P.&Sok, M. Increased fatty acid synthase activity in non-small cell lung cancer tissue is a weaker predictor of shorter patient survival than increased lipoprotein lipase activity. Arch Med Res. 41, 405-9 (2010).
18. Wang, Y. et al. Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer. Oncol Rep. 27, 1156-62 (2012).
19. Zaidi, N., Swinnen, J. V., Smans, K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res. 72, 3709-14 (2012).
20. Laing, R. E., Hess, P., Shen, Y., Wang, J., Hu, S. X. The role and impact of SNPs in pharmacogenomics and personalized medicine. Curr Drug Metab. 12, 460-86 (2011).
21. Eggert, S. L. et al. Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata. Am J Hum Genet. 91, 621-8 (2012).
22. Sinilnikova, O. M. et al. Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 16, 409-15 (2007).
23. Sinilnikova, O. M. et al. Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility. Carcinogenesis. 25, 2417-24 (2004).
24. Nguyen, P. L. et al. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol. 28, 3958-64 (2010).
25. Xing, J. et al. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer. (Oxford, England: 1990) 47, 1699-1707 (2011).
26. Zhou, F. et al. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer. 118, 937-46 (2012).
27. Cox, D. R. Regression models and life-tables. J R Stat Soc A Stat. Series B (Methodological), 34, 187-220 (1972).
28. Kaplan, E. L., Meier, P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53, 457-481 (1958).
29. Menendez, J. A., Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 7, 763-777 (2007).
30. Piyathilake, C. J. et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol. 31, 1068-1073 (2000).
31. Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology. 140, 1071-83 (2011).
32. Zhu, X. et al. Combined Phosphatase and Tensin Homolog (PTEN) Loss and Fatty Acid Synthase (FAS) Overexpression Worsens the Prognosis of Chinese Patients with Hepatocellular Carcinoma. Int J Mol Sci. 13, 9980-91 (2012).
33. Yoon, S. et al. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. J Biol Chem. 282, 26122-31 (2007).
34. Milgraum, L. Z., Witters, L. A., Pasternack, G. R., Kuhajda, F. P. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res. 3, 2115-20 (1997).
35. Blanchette, M. et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res. 14, 708-715 (2004).